Quantcast
Viewing all articles
Browse latest Browse all 3670

Tenaya raises about $53M; BeiGene’s PD-1 gets a first-line approval

Plus, news about Evotec and Osivax: Tenaya Therapeutics’ $52.5M public offering: The heart disease specialist intends to spend the proceeds from its offering of 75 million new shares to develop treatments ...

Viewing all articles
Browse latest Browse all 3670

Trending Articles